Big Lots Inc. (NYSE:BIG) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. Big Lots, Inc. (NYSE:BIG) shares after opening at $37.59 moved to $38.40 on last trade day and at the end of the day closed at $38.02. Company price to sales ratio in past twelve months was calculated as 0.41 and price to cash ratio as 31.88. Big Lots, Inc. (NYSE:BIG) showed a positive weekly performance of 21.43%.
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) wants to start life with a new slate. It has taken several measures to wipe out the old issues. The company took care of two major worries. It entered into a settlement agreement with the shareholders of Cypress Pharmaceuticals and with a one-time payment of $1.33 million got all claims waived off. In another move, the company’s Cypress subsidiary also settled its case with Texas Attorney General. Pernix Therapeutics Holdings Inc (NASDAQ:PTX) shares advanced 10.43% in last trading session and ended the day on $5.93. PTX return on equity ratio is recorded as -24.10% and its return on assets is -8.20%. Pernix Therapeutics Holdings Inc (NASDAQ:PTX) yearly performance is 17.19%.
Taubman Centers (NYSE:TCO) CFO Lisa A. Payne sold 4,000 shares of the company’s stock on the open market in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $69.91, for a total value of $279,640.00. Taubman Centers, Inc. (NYSE:TCO) shares moved up 0.86% in last trading session and was closed at $69.28 while trading in range of $68.81 – $69.98 – Taubman Centers, Inc. (NYSE:TCO) year to date (YTD) performance is 248.14%.
Aastrom Biosciences Inc (NASDAQ:ASTM)’s shares gained 34.81% to $6.70. The company announced that Nick Colangelo, President and CEO of Aastrom, will present at the 2014 Regen Med Investor Day on Wednesday, March 26 at 3:15 p.m. EDT at the Metropolitan Club in New York City. Aastrom Biosciences Inc (NASDAQ:ASTM) weekly performance is 84.90%. On last trading day company shares ended up $6.49. Aastrom Biosciences Inc (NASDAQ:ASTM) distance from 50-day simple moving average (SMA50) is 78.37%. Analysts mean target price for the company is $4.25.